Abstract
Nasopharyngeal carcinoma (NPC) is a popular malignant tumor of the head and neck which is endemic in the world, more than 75% of the NPC patients suffer from locoregionally advanced nasopharyngeal carcinoma (LA-NPC). The survival quality of these patients depends on the reliable prediction of NPC stages III and IVa. In this paper, we propose a two-stage framework to produce the classification probabilities for predicting NPC stages III and IVa. The preprocessing of MR images enhance the quality of images for further analysis. In stage one transfer learning is used to improve the classification effectiveness and the efficiency of CNN models training with limited images. Then in stage two the output of these models are aggregates using soft voting to boost the final prediction. The experimental results show the preprocessing is quite effective, the performance of transfer learning models perform better than the basic CNN model, and our ensemble model outperforms the single model as well as traditional methods, including the TNM staging system and the Radiomics method. Finally, the prediction accuracy boosted by the framework is, respectively, 0.81, indicating that our method achieves the SOTA effectiveness for LA-NPC stage prediction. In addition, the heatmaps generated with Class Activation Map technique illustrate the interpretability of the CNN models, and show their capability of assisting clinicians in medical diagnosis and follow-up treatment by producing discriminative regions related to NPC in the MR images.Graphic
Highlights
Nasopharyngeal carcinoma (NPC) is a popular malignant tumor in the world
Over 75% of patients suffer from locoregionally advanced Nasopharyngeal Carcinoma (LA-NPC) in stage III or IVa at the first diagnosis, where concurrent chemoradiotherapy (CCRT) and induction chemotherapy (IC) are suggested
The study declares that CCRT is sufficient for low-risk patients of LA-NPC, while IC is required for high-risk patients
Summary
Nasopharyngeal carcinoma (NPC) is a popular malignant tumor in the world. Stage describes the growth and spread of the NPC. There is a significant difference in the survival rate of NPC patients in the early stages (I, II) and late stages (III, IV). Different treatment options need to be selected for the patients in different stages. Over 75% of patients suffer from locoregionally advanced Nasopharyngeal Carcinoma (LA-NPC) in stage III or IVa at the first diagnosis, where concurrent chemoradiotherapy (CCRT) and induction chemotherapy (IC) are suggested. Aiming at improving the survival quality of the patients with advanced NPC, aggressive treatment options are not recommended for any patients in stage III/IVa [2]. The study declares that CCRT is sufficient for low-risk patients of LA-NPC (stage III), while IC is required for high-risk patients (stage IVa). An accurate treatment plan depends on effective LA-NPC stage prediction
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Computational Intelligence Systems
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.